Learn More
Medchemexpress LLC Halofuginone hydrobromide | 64924-67-0 | 495.59 | 5 MG

Supplier: Medchemexpress LLC HYN1584AR5MG
Halofuginone hydrobromide is an analytical standard of Halofuginone (hydrobromide) for research and analytical applications. This Febrifugine derivative is a competitive prolyl-tRNA synthetase inhibitor with a Ki of 18.3 nM. It specifically inhibits type-I collagen synthesis and attenuates osteoarthritis (OA) by inhibiting TGF-β activity. Furthermore, it acts as a potent pulmonary vasodilator by activating Kv channels and blocking voltage-gated, receptor-operated, and store-operated Ca2+ channels.
- Competitive prolyl-tRNA synthetase inhibitor
- Specific inhibitor of type-I collagen synthesis
- Attenuates osteoarthritis by inhibiting TGF-β activity
- Functions as a potent pulmonary vasodilator
- Possesses anti-malaria effects
- Exhibits anti-inflammatory effects
- Demonstrates anti-cancer effects
- Shows anti-fibrosis effects
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.